Skip to main navigation
Cartesian Therapeutics, Inc
  • About Us
    • Leadership
    • Board of Directors
    • Advisors
  • Science
    • mRNA Cell Therapy
    • Proprietary Platform
    • Manufacturing
    • Publications & Presentations
  • Pipeline
    • Descartes-08
    • Descartes-15
  • Patients
    • Clinical Trials
    • Patient Resources
  • Careers
  • Investors
    • Overview
    • News & Events
    • Stock Information
    • Financial Information
    • Corporate Governance
    • Investor Resources

SEC Filing Details

Financial Information
  • SEC Filings
  • Annual Reports

Document Details

Form
8-K
Filing Date
June 21, 2022
Document Date
June 21, 2022
Form Description
Report of unscheduled material events or corporate event
Filing Group
Current Reports
Company
Cartesian Therapeutics, Inc
Issuer
CARTESIAN THERAPEUTICS, INC.

Filing Formats

iXBRL
View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
XML - XBRL INSTANCE DOCUMENT
  • About Us
  • Science
  • Pipeline
  • Patients
  • Careers
  • Investors
  • Go to linkedin page
  • Go to Twitter page

7495 New Horizon Way, Frederick, MD 21703

info@cartesiantx.com

  • Global Privacy Notice
  • HCP Privacy Notice
  • Vendor Privacy Notice
  • Terms of Service
  • FCOI Policy
  • Expanded Access Policy
Cartesian Therapeutics, Inc

©2026 Cartesian Therapeutics, Inc. All Rights Reserved.